Treatment of cervical intraepithelial neoplasia and invasive squamous cell carcinoma by interferon.
Bornstein
J
J
Department of Obstetrics and Gynecology, Carmel Medical Center, Rehovot, Israel.
Ben-David
Y
Y
Atad
J
J
Pascal
B
B
Revel
M
M
Abramovici
H
H
D000287:Administration, Topical; D002278:Carcinoma in Situ / Q000209:etiology / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000628:therapy*; D002584:Cervix Uteri; D005260:Female; D006801:Humans; D007267:Injections; D015552:Injections, Intralesional; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D027383:Papillomaviridae; D011994:Recombinant Proteins / Q000627:therapeutic use; D014412:Tumor Virus Infections / Q000150:complications / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000628:therapy*
D011994:Recombinant Proteins; D007372:Interferons